Amptiv Biosciences
Cleveland, US · Founded 2024 · Delaware corporation
Founders & leadership
JB
Jonathan BellExecutive
Board
JA
Jon ArmstrongBoard director
Reported raises · per SEC filings
Form D private placements$500K disclosed across 2 rounds · 2024–2025
▶$300KraisedApr 2025 · 3 investors · Other Health CareRule 506(b)
▶$300KraisedApr 2025 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jon ArmstrongDirector
- Jonathan BellExecutive Officer, Director
- Offering amount
- $1.4M
- Amount sold
- $300K
- Proceeds to insiders
- $120K
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$200KraisedDec 2024 · 1 investors · Other Health CareRule 506(b)
▶$200KraisedDec 2024 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jon ArmstrongDirector
- Jonathan BellExecutive Officer, Director
- Offering amount
- $200K
- Amount sold
- $200K
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Amptiv Biosciences raised?
- Amptiv Biosciences has disclosed $500K raised across 2 rounds.
- Where is Amptiv Biosciences headquartered?
- Amptiv Biosciences is headquartered in Cleveland, US.